000 01228 a2200325 4500
005 20250518100207.0
264 0 _c20200608
008 202006s 0 0 chi d
022 _a1009-2137
024 7 _a10.19746/j.cnki.issn.1009-2137.2020.02.060
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJi, Ting-Ting
245 0 0 _a[Reaserch Advance on Inhibitor Targeting at the B-Cell Receptor Pathway in Chronic Lymphocytic Leukemia --Review].
_h[electronic resource]
260 _bZhongguo shi yan xue ye xue za zhi
_cApr 2020
300 _a708-712 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
650 0 4 _aPhosphatidylinositol 3-Kinases
650 0 4 _aProtein Kinase Inhibitors
650 0 4 _aProtein-Tyrosine Kinases
650 0 4 _aReceptors, Antigen, B-Cell
650 0 4 _aSignal Transduction
700 1 _aChen, Qiu-Ni
700 1 _aTao, Shan-Dong
700 1 _aYu, Liang
773 0 _tZhongguo shi yan xue ye xue za zhi
_gvol. 28
_gno. 2
_gp. 708-712
856 4 0 _uhttps://doi.org/10.19746/j.cnki.issn.1009-2137.2020.02.060
_zAvailable from publisher's website
999 _c30885837
_d30885837